Web-based Platform for Nutrition Management in Patients With Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: nutrtion care based on app.
- Who it may be relevant to
- Registry conditions: Nutrition. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Web-based Platform for Nutrition Management in Patients With Cancer: A Randomized Clinical Trial
Overview
It is crucial to promptly identify nutritional issues in these patients within the community and provide them with dietary guidance, nutritional counseling, and support. This study will be conducted in communities in Chengdu, Sichuan. Community management teams will register oncology patients, collecting information such as demographic data, tumor type, stage, specific treatment plan, treatment hospital, regularity of hospital admissions, and frequency of independent smartphone use. Registered patients will be screened based on inclusion and exclusion criteria. For those who meet the criteria, the community management team will contact them and recommend the use of a dedicated app developed by the research team. An initial nutritional assessment will also be conducted. Patients identified with nutritional risks will be directly referred to the research team's clinical nutritionists for face-to-face consultations. After additional tests, such as body composition analysis, necessary nutritional education and stepwise nutritional interventions will be provided. These patients will also use the app for dietary monitoring and nutritional guidance. For patients without nutritional risks, the app will be recommended for daily questionnaire completion and activity tracking.
Interventions
- Other nutrtion care based on app
Self-Intervention: During the period of staying at home, patients use the app developed by the team for self-intervention, including dietary monitoring and check-ins, nutritional risk assessment, learning of educational knowledge, and online expert consultations. Community Intervention: When nutritional risks are detected, pop-up alerts will notify patients to communicate with the community management team. Patients can seek basic nutritional consultations and receive advice from the community
Primary outcome measures
- body weight change [Time frame: baseline, pre-intervention；every 2 weeks after randomization until 6 moths.]
Secondary outcome measures (2)
- PG-SGA [Time frame: baseline, pre-intervention；every 2 weeks after randomization until 6 moths.]
- NRS2002 [Time frame: baseline, pre-intervention；every 2 weeks after randomization until 6 moths.]
Eligibility criteria
Inclusion criteria
- Pathologically confirmed malignant tumor;
- PG-SGA score of 4-9 points;
- Age: ≥18 years, with an expected survival time of more than 1 year;
- Possesses adequate cognitive and reading abilities to complete questionnaires and use the APP.
Exclusion criteria
- Presence of neurological or psychiatric disorders affecting cognitive function, including central nervous system metastasis of tumors;
- Suffering from conditions severely impacting digestion, metabolism, or food intake;
- Patients in the cachexia stage or refractory cachexia phase.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Supportive care
Study locations
China · 1 center
- West China hospital — Chengdu
Identifiers
NCT: NCT07307404 · 2024-2316